New research suggests the weight-loss drug Ozempic significantly reduces the risk of chronic kidney disease, heart failure, and stroke. Medical experts claim the drug's primary benefit is reducing systemic inflammation. The FDA is expected to update the drug's label to include these new therapeutic applications, while some studies even link it to improved mental health.















